Skip to main content
Gut logoLink to Gut
. 1976 Feb;17(2):119–121. doi: 10.1136/gut.17.2.119

Hepatitis-B surface antigen and cirrhosis in Iraq.

E H Boxall, T H Flewett, A Paton, S W Rassam
PMCID: PMC1411089  PMID: 1261882

Abstract

Hepatitis-B surface antigen was found in 58% of 64 patients with cirrhosis in Iraq using counter immunoelectrophoresis (CIE), radioimmunoassay (RIA), and three commercial haemagglutination tests--Auscell (Abbott Laboratories), Hepatest (Wellcome Reagents Ltd.), and Hepanosticon (Organon Teknika). CIE detected about half as many positives as the other methods; RIA was the most sensitive. The number of positive reactions was much higher than in any previously reported series of patients with cirrhosis and seven times higher than in a normal hospital control population.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony P. P., Vogel C. L., Sadikali F., Barker L. F., Peterson M. R. Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathology. Br Med J. 1972 Feb 12;1(5797):403–406. doi: 10.1136/bmj.1.5797.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bagshawe A. F., Parker A. M., Jindani A. Hepatitis-associated antigen in liver disease in Kenya. Br Med J. 1971 Jan 9;1(5740):88–89. doi: 10.1136/bmj.1.5740.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cayzer I., Dane D. S., Cameron C. H., Denning J. V. A rapid haemagglutination test for hepatitis-B antigen. Lancet. 1974 May 18;1(7864):947–949. doi: 10.1016/s0140-6736(74)91259-8. [DOI] [PubMed] [Google Scholar]
  4. Chrystie I. L., Islam M. N., Banatvala J. E. Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet. 1974 Jun 15;1(7868):1193–1194. doi: 10.1016/s0140-6736(74)91003-4. [DOI] [PubMed] [Google Scholar]
  5. Juji T., Yokochi T. Hemagglutination technique with erythrocyte coated with specific antibody for detection of Australia antigen. Jpn J Exp Med. 1969 Dec;39(6):615–620. [PubMed] [Google Scholar]
  6. Reed W. D., Stern R. B., Eddleston A. L., Williams R., Zuckerman A. J., Bowes A., Earl P. M. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet. 1973 Sep 29;2(7831):690–694. doi: 10.1016/s0140-6736(73)92534-8. [DOI] [PubMed] [Google Scholar]
  7. Reesink H. W., Duimel W. J., Brummelhuis H. G. Evaluation of a new haemagglutination technique for the demonstration of hepatitis-B antigen. Lancet. 1973 Dec 15;2(7842):1351–1353. doi: 10.1016/s0140-6736(73)93322-9. [DOI] [PubMed] [Google Scholar]
  8. Skinhoj P., Al-Kassab S. Letter: Hepatitis-B antigen in Iraq. Lancet. 1973 Dec 1;2(7840):1269–1269. doi: 10.1016/s0140-6736(73)91013-1. [DOI] [PubMed] [Google Scholar]
  9. Whittingham S., Mackay I. R., Thanabalasundrum R. S., Chuttani H. K., Manjuran R., Seah C. S., Yu M., Viranuvatti V. Chronic liver disease: differences in autoimmune serological reactions between Australians and Asians. Br Med J. 1973 Dec 1;4(5891):517–519. doi: 10.1136/bmj.4.5891.517. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES